Evid Invest
Who owns PHARWhat PHAR owns — n/a

Who owns Pharming Group N.V.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.

Institutional ownership of PHAR from SEC Form 13F filings across 11 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-06-30 reporting period, 11 institutions disclosed 30,019 shares of Pharming Group N.V. worth $413,010 — about 0% of shares outstanding; the largest disclosed holder is CITADEL ADVISORS LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

11

13F holders

$413,010

value, 2026 filers

0%

of shares outstanding (30,019 sh)

5

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of PHAR's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1CITADEL ADVISORS LLC11,972$162,3400.0%0%+17.5%
2MORGAN STANLEY11,500$159,7350.0%0%+0.1%
3Knoll Capital Management, LLC4,091$56,8230.0%0%+0.8%
4Silver Grove Financial Group, Inc.NEW1,071$14,8760.0%0%new
5Global Retirement Partners, LLCNEW456$6,3340.0%0%new
6Integrated Wealth Concepts LLCNEW380$5,2780.0%0%new
7BNP PARIBAS FINANCIAL MARKETS300$4,1670.0%0%-25.0%
8NewEdge Advisors, LLCNEW187$2,5960.0%0%new
9UBS Group AGNEW39$5420.0%0%new
10OSAIC HOLDINGS, INC.16$2220.0%0%-87.5%
11Larson Financial Group LLC7$970.0%0%-98.0%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.